Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Study Completion Date

June 30, 2003

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

pentostatin

Trial Locations (5)

11733

North Shore Hematology/Oncology Associates, P.C., East Setauket

13210

Hematology Oncology Associates of Central New York, P.C., Syracuse

20735

Oncology-Hematology Associates, P.A., Clinton

92270

Cancer and Blood Institute of the Desert, Rancho Mirage

96001

Redding Medical Center, Redding

Sponsors
All Listed Sponsors
lead

Pharmatech Oncology

INDUSTRY

NCT00026351 - Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter